<?xml version="1.0" encoding="UTF-8"?>
<p id="p0390">Although an effective live attenuated vaccine is available against yellow fever, it is contraindicated in significantly immunosuppressed patients due to the risk of vaccine-associated neurotropic and viscerotropic disease [
 <xref rid="bib9" ref-type="bibr">9</xref>]. Such travelers who have not been vaccinated against yellow fever should be discouraged from traveling to endemic areas. If travel is unavoidable, then they should be informed of the risk of yellow fever in their destination and the importance of strict mosquito bite avoidance measures [
 <xref rid="bib18" ref-type="bibr">18</xref>]. In general, the risk of developing yellow fever is 10 times higher from travel to sub-Saharan Africa than travel to South America. If a traveler requires an International Certificate of Vaccination or Prophylaxis (ICVP) for entry to their destination, then a Medical Letter of Exemption (MLoE) may be issued instead by their treating specialist or travel clinic. This should be taken into consideration by the destination country, but patients should be aware that it may not guarantee entry [
 <xref rid="bib19" ref-type="bibr">19</xref>]. Guidance on how to issue an exemption can be found here [
 <xref rid="bib20" ref-type="bibr">20</xref>], and an example may be viewed here 
 <ext-link ext-link-type="uri" xlink:href="https://nathnacyfzone.org.uk/factsheet/6/medical-letter-of-exemption" id="interref1" xmlns:xlink="http://www.w3.org/1999/xlink">https://nathnacyfzone.org.uk/factsheet/6/medical-letter-of-exemption</ext-link> [
 <xref rid="bib21" ref-type="bibr">21</xref>].
</p>
